ASAP
|
July 27, 2012

House Passes Bill Imposing Regulatory Moratorium until Unemployment Drops

After fixing a typographical error in the bill, on Thursday the House of Representatives voted 245-172

ASAP
|
July 27, 2012

Study Suggests Employers Could Benefit by Providing Fixed Contributions for Private Insurance Exchange Purchases

An issue brief released by the Employee Benefit Research Institute (EBRI) has concluded that employers

ASAP
|
July 27, 2012

Survey finds that Most Employers Will Not Drop Health Insurance Care Coverage as a Result of the Affordable Care Act

According to a recent survey conducted by financial consulting firm Deloitte, the majority of employers

ASAP
|
July 26, 2012

Legislation to Amend the NLRA Examined at House Hearing

On Wednesday the House Subcommittee on Health, Employment, Labor, and Pensions held a hearing to discuss

ASAP
|
July 26, 2012

OSHA Issues Final Rule Implementing Whistleblower Provisions of the Surface Transportation Assistance Act (STAA)

The Occupational Safety and Health Administration (OSHA) has issued a final rule (pdf) implementing the

Insight
|
July 26, 2012

Second Circuit Makes Key Holdings Involving Proof Requirements in Individual Discrimination Cases and Litigation Hold Requirements

Recently, in Chin v. Port Authority of New York & New Jersey, 2012 U.S. App. LEXIS 14088 (2d Cir. July

ASAP
|
July 26, 2012

Legislation to Amend the NLRA Examined at House Hearing

On Wednesday the House Subcommittee on Health, Employment, Labor, and Pensions held a hearing to discuss

ASAP
|
July 26, 2012

Ninth Circuit Holds Pharmaceutical Sales Reps are Exempt Administrative Employees

In a consolidated decision in three actions against Bayer Corporation, Wyeth Pharmaceuticals, and Roche

ASAP
|
July 26, 2012

CBO Provides New Healthcare Cost Estimates

The Congressional Budget Office (CBO) has released two new cost estimates associated with the Affordable

ASAP
|
July 26, 2012

Ninth Circuit Holds Pharmaceutical Sales Reps are Exempt Administrative Employees

In a consolidated decision in three actions against Bayer Corporation, Wyeth Pharmaceuticals, and Roche

Pages